These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 21413974

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
    Banerjee KJ, Glasson C, O'Flaherty SJ.
    Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954
    [Abstract] [Full Text] [Related]

  • 3. Thickened saliva after effective management of drooling with botulinum toxin A.
    Erasmus CE, Van Hulst K, Van Den Hoogen FJ, Van Limbeek J, Roeleveld N, Veerman EC, Rotteveel JJ, Jongerius PH.
    Dev Med Child Neurol; 2010 Jun; 52(6):e114-8. PubMed ID: 20163435
    [Abstract] [Full Text] [Related]

  • 4. Treatment of sialorrhea in children with cerebral palsy: a double-blind placebo controlled trial.
    Alrefai AH, Aburahma SK, Khader YS.
    Clin Neurol Neurosurg; 2009 Jan; 111(1):79-82. PubMed ID: 18977585
    [Abstract] [Full Text] [Related]

  • 5. Drooling in children with cerebral palsy: effect of salivary flow reduction on daily life and care.
    Van der Burg JJ, Jongerius PH, Van Hulst K, Van Limbeek J, Rotteveel JJ.
    Dev Med Child Neurol; 2006 Feb; 48(2):103-7. PubMed ID: 16417664
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders.
    Reid SM, Johnstone BR, Westbury C, Rawicki B, Reddihough DS.
    Dev Med Child Neurol; 2008 Feb; 50(2):123-8. PubMed ID: 18201301
    [Abstract] [Full Text] [Related]

  • 8. Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: a prospective double-blind trial.
    Chinnapongse R, Gullo K, Nemeth P, Zhang Y, Griggs L.
    Mov Disord; 2012 Feb; 27(2):219-26. PubMed ID: 21887710
    [Abstract] [Full Text] [Related]

  • 9. Salivary gland botulinum toxin injections for drooling in children with cerebral palsy and neurodevelopmental disability: a systematic review.
    Rodwell K, Edwards P, Ware RS, Boyd R.
    Dev Med Child Neurol; 2012 Nov; 54(11):977-87. PubMed ID: 22946706
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Botulinum toxin effect on salivary flow rate in children with cerebral palsy.
    Jongerius PH, Rotteveel JJ, van Limbeek J, Gabreëls FJ, van Hulst K, van den Hoogen FJ.
    Neurology; 2004 Oct 26; 63(8):1371-5. PubMed ID: 15505151
    [Abstract] [Full Text] [Related]

  • 13. Botulinum Toxin A for Sialorrhoea Associated with Neurological Disorders: Evaluation of the Relationship between Effect of Treatment and the Number of Glands Treated.
    Restivo DA, Panebianco M, Casabona A, Lanza S, Marchese-Ragona R, Patti F, Masiero S, Biondi A, Quartarone A.
    Toxins (Basel); 2018 Jan 27; 10(2):. PubMed ID: 29382036
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study.
    Wu KP, Ke JY, Chen CY, Chen CL, Chou MY, Pei YC.
    J Child Neurol; 2011 Jul 27; 26(7):838-43. PubMed ID: 21551374
    [Abstract] [Full Text] [Related]

  • 17. Drooling: are botulinum toxin injections into the major salivary glands a good treatment option?
    Nordgarden H, Østerhus I, Møystad A, Asten P, Johnsen UL, Storhaug K, Loven JØ.
    J Child Neurol; 2012 Apr 27; 27(4):458-64. PubMed ID: 21940695
    [Abstract] [Full Text] [Related]

  • 18. Relevance of intraglandular injections of Botulinum toxin for the treatment of sialorrhea in children with cerebral palsy: a review.
    Porte M, Chaléat-Valayer E, Patte K, D'Anjou MC, Boulay C, Laffont I.
    Eur J Paediatr Neurol; 2014 Nov 27; 18(6):649-57. PubMed ID: 24931915
    [Abstract] [Full Text] [Related]

  • 19. Botulinum toxin type A and B for the reduction of hypersalivation in children with neurological disorders: a focus on effectiveness and therapy adherence.
    Schroeder AS, Kling T, Huss K, Borggraefe I, Koerte IK, Blaschek A, Jahn K, Heinen F, Berweck S.
    Neuropediatrics; 2012 Feb 27; 43(1):27-36. PubMed ID: 22430158
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.